atherosclerosis Archives
A new contributor to atherosclerosis
Jan. 27, 2020—Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis.
VUMC investigators receive Keck Foundation award for novel atherosclerosis research
Aug. 26, 2019—A team of researchers has received a $1 million grant from the W.M. Keck Foundation to explore a novel model of atherosclerosis development.
Heart Institute offering new option to clear carotid arteries
Jul. 24, 2019—Vanderbilt Heart and Vascular Institute is now offering a new procedure that reduces stroke risk for many high-risk patients during interventions for extracranial carotid disease
New look at atherosclerosis
Jul. 11, 2019—A new imaging method makes it possible to directly measure cell division and changes in metabolism in atherosclerotic plaques.
Scavengers “protect” HDL
Jun. 29, 2018—Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.
Team sees success clearing blocked coronary arteries
Apr. 9, 2015—When atherosclerosis develops in the coronary arteries over a period of time, complete blockage of that artery can result in chest pain, shortness of breath and decreased quality of life.
Target for atherosclerosis therapies
Dec. 17, 2014—A newly identified “atheroprotective” gene is a tool for exploring plaque pathophysiology and may be a good target for therapies to slow atherosclerosis progression.
Protein implicated in atherosclerosis
Nov. 25, 2014—Vanderbilt researchers have discovered a new target for the prevention of atherosclerotic plaque development and cardiovascular disease.
Major grant spurs deeper look into ‘good cholesterol’
Aug. 21, 2014—In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.
Early study reveals ‘nuclear’ strategy for atherosclerosis
Apr. 18, 2013—Vanderbilt University scientists have discovered a potential new strategy for lowering cholesterol and triglyceride levels and stopping atherosclerosis and fatty liver disease.
Move out, cholesterol
Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.
